Market Place
Sourcing Support
Serina Therapeutics Appoints Dr. Jay to its Board of Directors
12 Feb 2025 //
GLOBENEWSWIRE
Serina Therapeutics Receives $5M Tranche for Parkinson`s Trial
03 Feb 2025 //
GLOBENEWSWIRE
Serina Therapeutics Announces Sale of UniverXome Subsidiary
15 Jan 2025 //
GLOBENEWSWIRE
Serina Therapeutics Welcomes Karen J. to its Board of Directors
14 Jan 2025 //
GLOBENEWSWIRE
Serina to Present at LNP Immunogenicity & Toxicity Summit
11 Dec 2024 //
GLOBENEWSWIRE
Serina Therapeutics Secures $10M For Parkinson`s Disease Trial
02 Dec 2024 //
GLOBENEWSWIRE
Serina Therapeutics Reports Q3 2024 Financial Results & Business
12 Nov 2024 //
GLOBENEWSWIRE
Serina Therapeutics Makes Grants to Employees Under Inducement Plan
11 Nov 2024 //
GLOBENEWSWIRE
Serina Therapeutics Presents at Injectables Summit
02 Oct 2024 //
GLOBENEWSWIRE
Serina Therapeutics To Present At H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Serina Therapeutics Reports Q2 2024 Results And Business Highlights
09 Aug 2024 //
GLOBENEWSWIRE
Serina Therapeutics To Present POZ-Lipid Tech Data At MRNA Summit
29 Jul 2024 //
GLOBENEWSWIRE
Serina Therapeutics Appoints Srini Tenjarla As SVP Of CMC And Formulation
18 Jul 2024 //
GLOBENEWSWIRE
Enable, Serina Announce SER-252 + enFuse Agreement For Parkinson`s
15 May 2024 //
GLOBENEWSWIRE
Serina Therapeutics Reports Q1 2024 Results, Business Highlights
14 May 2024 //
GLOBENEWSWIRE
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17 Apr 2024 //
GLOBENEWSWIRE
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
26 Mar 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.